AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Myval Global Study of Myval™ THV Series Implanted in Patients With Native Severe Aortic Valve Stenosis.

Recruitingn/aAges 18 Years - anyAllMeril Life Sciences Pvt. Ltd.
💬

In plain words

What the trial is, and whether it could suit you

A retrospective, multinational, multicentre, observational study in patients presenting with native severe aortic valve stenosis and treated with Myval™ Transcatheter Heart Valve Series in real-world setting.

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * All patients of this study must have received Myval™ THV series for treatment of native severe aortic stenosis and completed a minimum of 30-day follow-up. Exclusion Criteria: * No
💊

What it tests

  • Myval Transcatheter Heart Valve Series
📍

Where

8 sites
North Estonia Medical center
Tallinn, Estonia
Clinical Institute Saint Ambrogio
Milan, Italy
Amphia Ziekenhui
Breda, Netherlands
University of Gdansk
Gdansk, Poland
University Medical Centre Ljubljana
Ljubljana, Slovenia
Hospital Universitario de Gran Canaria Dr. Negrin
Las Palmas de Gran Canaria, Spain
Hospital Cliinico Univertistario de Valladolid
Valladolid, Spain
Kocaeli University School of Medicine
Kocaeli, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy